Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument, Reagent, Consumable, Service), Price, Application, End User - Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 MARKET STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of secondary sources
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.2.2 PRODUCT-BASED MARKET ESTIMATION
  • 2.2.3 PRIMARY RESEARCH VALIDATION
• 2.3 DATA TRIANGULATION AND MARKET BREAKDOWN
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 STUDY ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ASSESSMENT
  • 2.6.1 RISK ASSESSMENT ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT AND COUNTRY (2023)
• 4.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGIONAL MIX, 2022-2029 (USD MILLION)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing incidence of blood disorders
    • 5.2.1.2 Growing number of blood donations
    • 5.2.1.3 Rising technological advancements
    • 5.2.1.4 Integration of hematology analyzers with flow cytometry
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of advanced hematology analyzers
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing uptake of automated hematology analyzers
    • 5.2.3.2 Growth potential of emerging economies
    • 5.2.3.3 Emergence of microfluidics
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stringent regulatory guidelines
    • 5.2.4.2 Shortage of skilled professionals in emerging markets
• 5.3 REGULATORY SCENARIO
  • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
  • 5.3.2 REGULATORY TRENDS
    • 5.3.2.1 North America
      • 5.3.2.1.1 US
    • 5.3.2.2 Europe
    • 5.3.2.3 Asia Pacific
      • 5.3.2.3.1 India
      • 5.3.2.3.2 China
• 5.4 REIMBURSEMENT SCENARIO
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RESEARCH & DEVELOPMENT
  • 5.5.2 PROCUREMENT & PRODUCT DEVELOPMENT
  • 5.5.3 MARKETING, SALES, AND DISTRIBUTION
• 5.6 SUPPLY CHAIN ANALYSIS
  • 5.6.1 PROMINENT COMPANIES
  • 5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
  • 5.6.3 END USERS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 DEGREE OF COMPETITION
  • 5.8.2 BARGAINING POWER OF BUYERS
  • 5.8.3 BARGAINING POWER OF SUPPLIERS
  • 5.8.4 THREAT OF NEW ENTRANTS
  • 5.8.5 THREAT OF SUBSTITUTES
• 5.9 TRADE DATA ANALYSIS
• 5.10 PATENT ANALYSIS
• 5.11 PRICING ANALYSIS
• 5.12 TECHNOLOGY ANALYSIS
  • 5.12.1 KEY TECHNOLOGIES
    • 5.12.1.1 Flow cytometry
    • 5.12.1.2 Digital microscopy and image analysis
    • 5.12.1.3 Polymerase chain reaction (PCR) and next-generation sequencing (NGS)
    • 5.12.1.4 Microfluidics
  • 5.12.2 ADJACENT TECHNOLOGIES
    • 5.12.2.1 Bioinformatics
    • 5.12.2.2 Wearable health technology
    • 5.12.2.3 Point-of-care testing (POCT) devices
  • 5.12.3 COMPLEMENTARY TECHNOLOGIES
    • 5.12.3.1 Immunohistochemistry (IHC)
    • 5.12.3.2 Spectrophotometry
    • 5.12.3.3 Serological testing
• 5.13 KEY CONFERENCES AND EVENTS, 2024
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 KEY BUYING CRITERIA
• 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 UNMET NEEDS
• 5.18 USE OF GENERATIVE AI IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET

6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE

• 6.1 INTRODUCTION
• 6.2 HEMATOLOGY PRODUCTS & SERVICES
  • 6.2.1 REAGENTS & CONSUMABLES
    • 6.2.1.1 Hematology reagents
      • 6.2.1.1.1 Growing preference for reagent rental business models to drive market
    • 6.2.1.2 Hematology consumables
      • 6.2.1.2.1 Recurring requirement to boost demand
    • 6.2.1.3 Controls & calibrators
      • 6.2.1.3.1 Ability to monitor multiple parameters to fuel uptake
    • 6.2.1.4 Slide stainers & makers
      • 6.2.1.4.1 Ability to provide reliable & uniform staining results to fuel uptake
  • 6.2.2 INSTRUMENTS
    • 6.2.2.1 5-part and 6-part fully automated hematology analyzers
      • 6.2.2.1.1 Identification and classification of WBCs to drive market
    • 6.2.2.2 3-part fully automated hematology analyzers
      • 6.2.2.2.1 Low maintenance costs to fuel uptake
    • 6.2.2.3 Point-of-care testing hematology analyzers
      • 6.2.2.3.1 Increasing preference towards home testing of blood levels to support market growth
    • 6.2.2.4 Semi-automated hematology analyzers
      • 6.2.2.4.1 Need for manual interruption to restrain market adoption
  • 6.2.3 SERVICES
    • 6.2.3.1 High adoption of diagnostic techniques to boost demand
• 6.3 HEMOSTASIS PRODUCTS & SERVICES
  • 6.3.1 HEMOSTASIS REAGENTS & CONSUMABLES
    • 6.3.1.1 Rising prevalence of coagulation disorders to support growth
  • 6.3.2 HEMOSTASIS INSTRUMENTS
    • 6.3.2.1 High productivity with low complexities to drive market
  • 6.3.3 HEMOSTASIS SERVICES
    • 6.3.3.1 Advancements in hemostasis diagnostic techniques to support market growth
• 6.4 IMMUNOHEMATOLOGY PRODUCTS & SERVICES
  • 6.4.1 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES
    • 6.4.1.1 Development of novel immunohematology reagents to drive market
  • 6.4.2 IMMUNOHEMATOLOGY INSTRUMENTS
    • 6.4.2.1 Growing automation in immunohematology labs to boost demand
  • 6.4.3 SERVICES
    • 6.4.3.1 Provision of customer-focused care to support market growth

7 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE

• 7.1 INTRODUCTION
• 7.2 LOW-RANGE HEMATOLOGY ANALYZERS
  • 7.2.1 LOW OPERATING EXPENSES TO BOOST DEMAND
• 7.3 HIGH-RANGE HEMATOLOGY ANALYZERS
  • 7.3.1 HIGH ACCURACY AND MULTI-PARAMETER APPROACH TO DRIVE MARKET
• 7.4 MID-RANGE HEMATOLOGY ANALYZERS
  • 7.4.1 INTEGRATION WITH QUALITY CONTROL SOFTWARE TO SUPPORT MARKET GROWTH

8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 HEMORRHAGIC CONDITIONS
  • 8.2.1 ABILITY TO TRACK HEMOGLOBIN AND HEMATOCRIT VALUES TO DRIVE MARKET
• 8.3 INFECTIOUS DISEASES
  • 8.3.1 AVAILABILITY OF HIGH-RESOLUTION HEMATOLOGY SCREENING TO PROPEL MARKET
• 8.4 IMMUNE SYSTEM DISORDERS
  • 8.4.1 GROWING USE OF POC DIAGNOSTICS AND IMMUNOASSAYS TO PROPEL MARKET
• 8.5 BLOOD CANCER
  • 8.5.1 DETERMINATION OF HEMATOLOGICAL MALIGNANCIES TO FUEL UPTAKE
• 8.6 ANEMIA
  • 8.6.1 ABILITY TO IDENTIFY ISOCHROMATIC AND MICROCYTIC ANEMIA TO SUPPORT MARKET GROWTH
• 8.7 OTHER APPLICATIONS

9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE

• 9.1 INTRODUCTION
• 9.2 STANDALONE ANALYZERS
  • 9.2.1 HIGH UPTAKE IN HOSPITALS AND REFERENCE LABORATORIES FOR CRITICAL CARE SETTINGS TO PROPEL MARKET
• 9.3 POINT-OF-CARE ANALYZERS
  • 9.3.1 LOW SAMPLE REQUIREMENTS AND REMOTE CARE AVAILABILITY TO BOOST DEMAND

10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 COMMERCIAL SERVICE PROVIDERS
  • 10.2.1 GROWING OUTSOURCING OF R&D ACTIVITIES AND ABILITY TO PERFORM HIGH VOLUME OF TESTS TO PROPEL MARKET
• 10.3 HOSPITAL LABORATORIES
  • 10.3.1 PROVISION OF POC & FULLY AUTOMATED ANALYZERS TO DRIVE MARKET
• 10.4 GOVERNMENT REFERENCE LABORATORIES
  • 10.4.1 FREE SERVICES AND RAPID TURNAROUND TIME TO FUEL UPTAKE
• 10.5 RESEARCH & ACADEMIC INSTITUTES
  • 10.5.1 INCREASING NUMBER OF DRUG DISCOVERY & RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH

11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 Rising incidence of anemia and hemophilia to drive market
  • 11.2.2 CANADA
    • 11.2.2.1 Growth in organ transplantation procedures to boost demand
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Rising prevalence of HIV to drive market
  • 11.3.2 FRANCE
    • 11.3.2.1 Stringent regulatory protocols in diagnostics to propel market
  • 11.3.3 UK
    • 11.3.3.1 Rising number of organ transplant procedures to support market growth
  • 11.3.4 ITALY
    • 11.3.4.1 Growing acceptance of hematology-based diagnostics to boost demand
  • 11.3.5 SPAIN
    • 11.3.5.1 Rising establishment of reference laboratories to drive market
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 CHINA
    • 11.4.1.1 Large target patient population to drive market
  • 11.4.2 JAPAN
    • 11.4.2.1 Rising cases of influenza to support market growth
  • 11.4.3 INDIA
    • 11.4.3.1 Rising cases of dengue and malaria to boost demand
  • 11.4.4 AUSTRALIA
    • 11.4.4.1 Rising prevalence of celiac disease to drive market
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 High healthcare expenditure and introduction of medical coverage for blood transfusion to support market growth
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 BRAZIL
    • 11.5.1.1 Investments by leading hematology analyzers & reagent manufacturers to drive market
  • 11.5.2 MEXICO
    • 11.5.2.1 Growing requirement for glycosylated hemoglobin analysis tests to fuel uptake
  • 11.5.3 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 GCC COUNTRIES
    • 11.6.1.1 Developments in healthcare infrastructure to drive market
  • 11.6.2 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
• 12.3 REVENUE ANALYSIS
• 12.4 MARKET SHARE ANALYSIS
  • 12.4.1 HEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • 12.4.2 HEMOSTASIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • 12.4.3 IMMUNOHEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • 12.4.4 RANKING OF KEY MARKET PLAYERS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPETITIVE FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Product & service footprint
    • 12.5.5.3 Application footprint
    • 12.5.5.4 End-user footprint
    • 12.5.5.5 Region footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 SYSMEX CORPORATION
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product/Service launches
      • 13.1.1.3.2 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 DANAHER CORPORATION
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Services offered
    • 13.1.2.3 MnM view
      • 13.1.2.3.1 Key strengths
      • 13.1.2.3.2 Strategic choices
      • 13.1.2.3.3 Weaknesses and competitive threats
  • 13.1.3 SIEMENS HEALTHINEERS
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product/Service launches
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Services offered
    • 13.1.4.3 MnM view
      • 13.1.4.3.1 Key strengths
      • 13.1.4.3.2 Strategic choices
      • 13.1.4.3.3 Weaknesses and competitive threats
  • 13.1.5 ABBOTT LABORATORIES
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product approvals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 DIATRON
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Expansions
  • 13.1.7 DREW SCIENTIFIC
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Services offered
  • 13.1.8 BIO-RAD LABORATORIES, INC.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product/Service launches & enhancements
      • 13.1.8.3.2 Deals
  • 13.1.9 HORIBA, LTD.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product/Service launches & approvals
  • 13.1.10 NIHON KOHDEN CORPORATION
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product/Service launches
      • 13.1.10.3.2 Expansions
  • 13.1.11 EKF DIAGNOSTICS HOLDINGS PLC
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product/Service enhancements
      • 13.1.11.3.2 Deals
  • 13.1.12 BOULE DIAGNOSTICS AB
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Services offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 PRODUCT/SERVICE LAUNCHES
      • 13.1.12.3.2 Deals
  • 13.1.13 F. HOFFMANN-LA ROCHE LTD.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Services offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 BIOSYSTEMS: COMPANY OVERVIEW
  • 13.2.2 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • 13.2.3 DRUCKER DIAGNOSTICS: COMPANY OVERVIEW
  • 13.2.4 ELITECH GROUP SAS: COMPANY OVERVIEW
  • 13.2.5 ACCUREX: COMPANY OVERVIEW
  • 13.2.6 STRECK: COMPANY OVERVIEW
  • 13.2.7 NEOMEDICA: COMPANY OVERVIEW
  • 13.2.8 CPC DIAGNOSTICS PVT. LTD.: COMPANY OVERVIEW
  • 13.2.9 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • 13.2.10 SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • 13.2.11 PZ CORMAY S.A.: COMPANY OVERVIEW
  • 13.2.12 PIXCELL MEDICAL: COMPANY OVERVIEW
  • 13.2.13 RAYTO LIFE AND ANALYTICAL SCIENCES CO. LTD.: COMPANY OVERVIEW
  • 13.2.14 ANALYTICON BIOTECHNOLOGIES GMBH: COMPANY OVERVIEW
  • 13.2.15 TULIP DIAGNOSTICS (P) LTD.: COMPANY OVERVIEW

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

List of Tables

• TABLE 1 NORTH AMERICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
• TABLE 2 EUROPE: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
• TABLE 3 ASIA PACIFIC: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
• TABLE 4 LATIN AMERICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
• TABLE 5 MIDDLE EAST & AFRICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
• TABLE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 7 IMPORT DATA FOR HEMATOLOGY ANALYZERS (HS CODE 902780), BY COUNTRY, 2019-2023 (USD)
• TABLE 8 EXPORT DATA FOR HEMATOLOGY ANALYZERS (HS CODE 902780), BY COUNTRY, 2019-2023 (USD)
• TABLE 9 AVERAGE SELLING PRICE TREND OF HEMATOLOGY PRODUCTS, BY REGION, 2021-2023
• TABLE 10 HEMATOLOGY ANALYZERS AND REAGENTS: LIST OF MAJOR CONFERENCES & EVENTS
• TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMATOLOGY PRODUCTS (%)
• TABLE 12 KEY BUYING CRITERIA FOR HEMATOLOGY ANALYZERS AND REAGENTS PRODUCTS
• TABLE 13 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: CURRENT UNMET NEEDS
• TABLE 14 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 15 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 16 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 17 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 18 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 19 HEMATOLOGY REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 20 HEMATOLOGY CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 21 HEMATOLOGY CONTROLS & CALIBRATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 22 HEMATOLOGY SLIDE STAINERS & MAKERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 23 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 24 HEMATOLOGY INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 25 5-PART AND 6-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 26 3-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 27 POINT-OF-CARE TESTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 28 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 29 HEMATOLOGY SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 30 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 31 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 32 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 33 HEMOSTASIS INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 34 HEMOSTASIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 35 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 36 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 37 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 38 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 39 IMMUNOHEMATOLOGY SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 40 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022-2029 (USD MILLION)
• TABLE 41 LOW-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 42 HIGH-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 43 MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 44 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 45 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HEMORRHAGIC CONDITIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 46 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 47 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 48 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR BLOOD CANCER, BY REGION, 2022-2029 (USD MILLION)
• TABLE 49 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR ANEMIA, BY REGION, 2022-2029 (USD MILLION)
• TABLE 50 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 51 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022-2029 (USD MILLION)
• TABLE 52 STANDALONE HEMATOLOGY ANALYZERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 53 POINT-OF-CARE HEMATOLOGY ANALYZERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 54 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 55 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 56 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 57 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR GOVERNMENT REFERENCE LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 59 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 60 HEMATOLOGY ANALYZERS VOLUME, BY TYPE, 2023 (UNITS)
• TABLE 61 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 62 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 63 NORTH AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 64 NORTH AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 65 NORTH AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 66 NORTH AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 67 NORTH AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 68 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022-2029 (USD MILLION)
• TABLE 69 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 70 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022-2029 (USD MILLION)
• TABLE 71 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 72 US: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 73 US: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 74 US: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 75 US: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 76 US: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 77 US: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 78 CANADA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 79 CANADA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 80 CANADA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 81 CANADA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 82 CANADA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 83 CANADA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 84 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 85 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 86 EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 87 EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 88 EUROPE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 89 EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 90 EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 91 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022-2029 (USD MILLION)
• TABLE 92 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 93 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022-2029 (USD MILLION)
• TABLE 94 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 95 GERMANY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 96 GERMANY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 97 GERMANY: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 98 GERMANY: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 99 GERMANY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 100 GERMANY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 101 FRANCE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 102 FRANCE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 103 FRANCE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 104 FRANCE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 105 FRANCE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 106 FRANCE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 107 UK: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 108 UK: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 109 UK: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 110 UK: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 111 UK: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 112 UK: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 113 ITALY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 114 ITALY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 115 ITALY: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 116 ITALY: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 117 ITALY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 118 ITALY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 119 SPAIN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 120 SPAIN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 121 SPAIN: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 122 SPAIN: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 123 SPAIN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 124 SPAIN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 125 REST OF EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 126 REST OF EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 127 REST OF EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 128 REST OF EUROPE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 129 REST OF EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 130 REST OF EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 131 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 132 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 133 ASIA PACIFIC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 134 ASIA PACIFIC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 135 ASIA PACIFIC: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 136 ASIA PACIFIC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 137 ASIA PACIFIC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 138 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022-2029 (USD MILLION)
• TABLE 139 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 140 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022-2029 (USD MILLION)
• TABLE 141 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 142 CHINA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 143 CHINA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 144 CHINA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 145 CHINA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 146 CHINA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 147 CHINA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 148 JAPAN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 149 JAPAN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 150 JAPAN: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 151 JAPAN: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 152 JAPAN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 153 JAPAN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 154 INDIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 155 INDIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 156 INDIA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 157 INDIA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 158 INDIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 159 INDIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 160 AUSTRALIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 161 AUSTRALIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 162 AUSTRALIA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 163 AUSTRALIA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 164 AUSTRALIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 165 AUSTRALIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 166 SOUTH KOREA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 167 SOUTH KOREA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 168 SOUTH KOREA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 169 SOUTH KOREA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 170 SOUTH KOREA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 171 SOUTH KOREA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 172 REST OF ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 173 REST OF ASIA PACIFIC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 174 REST OF ASIA PACIFIC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 175 REST OF ASIA PACIFIC: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 176 REST OF ASIA PACIFIC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 177 REST OF ASIA PACIFIC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 178 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 179 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 180 LATIN AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 181 LATIN AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 182 LATIN AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 183 LATIN AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 184 LATIN AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 185 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022-2029 (USD MILLION)
• TABLE 186 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 187 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022-2029 (USD MILLION)
• TABLE 188 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 189 BRAZIL: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 190 BRAZIL: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 191 BRAZIL: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 192 BRAZIL: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 193 BRAZIL: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 194 BRAZIL: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 195 MEXICO: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 196 MEXICO: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 197 MEXICO: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 198 MEXICO: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 199 MEXICO: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 200 MEXICO: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 201 REST OF LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 202 REST OF LATIN AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 203 REST OF LATIN AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 204 REST OF LATIN AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 205 REST OF LATIN AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 206 REST OF LATIN AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 207 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 208 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 209 MIDDLE EAST & AFRICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 210 MIDDLE EAST & AFRICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 211 MIDDLE EAST & AFRICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 212 MIDDLE EAST & AFRICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 213 MIDDLE EAST & AFRICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 214 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022-2029 (USD MILLION)
• TABLE 215 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 216 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022-2029 (USD MILLION)
• TABLE 217 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 218 GCC COUNTRIES: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 219 GCC COUNTRIES: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 220 GCC COUNTRIES: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 221 GCC COUNTRIES: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 222 GCC COUNTRIES: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 223 GCC COUNTRIES: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 224 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 225 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 226 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 227 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 228 REST OF MIDDLE EAST & AFRICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 229 REST OF MIDDLE EAST & AFRICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 230 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
• TABLE 231 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEGREE OF COMPETITION
• TABLE 232 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT & SERVICE FOOTPRINT
• TABLE 233 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: APPLICATION FOOTPRINT
• TABLE 234 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: END-USER FOOTPRINT
• TABLE 235 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGION FOOTPRINT
• TABLE 236 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
• TABLE 237 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
• TABLE 238 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 239 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEALS, JANUARY 2020-JUNE 2024
• TABLE 240 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: EXPANSIONS, JANUARY 2020-JUNE 2024
• TABLE 241 SYSMEX CORPORATION: COMPANY OVERVIEW
• TABLE 242 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 243 SYSMEX CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 244 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2020-JUNE 2024
• TABLE 245 DANAHER CORPORATION: COMPANY OVERVIEW
• TABLE 246 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 247 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
• TABLE 248 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED
• TABLE 249 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 250 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEALS, JANUARY 2020-JUNE 2024
• TABLE 251 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
• TABLE 252 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS/SERVICES OFFERED
• TABLE 253 ABBOTT LABORATORIES: COMPANY OVERVIEW
• TABLE 254 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
• TABLE 255 ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 256 DIATRON: COMPANY OVERVIEW
• TABLE 257 DIATRON: PRODUCTS/SERVICES OFFERED
• TABLE 258 DIATRON: EXPANSIONS, JANUARY 2020-JUNE 2024
• TABLE 259 DREW SCIENTIFIC: COMPANY OVERVIEW
• TABLE 260 DREW SCIENTIFIC: PRODUCTS/SERVICES OFFERED
• TABLE 261 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
• TABLE 262 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
• TABLE 263 BIO-RAD LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2020-JUNE 2024
• TABLE 264 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2020-JUNE 2024
• TABLE 265 HORIBA, LTD.: COMPANY OVERVIEW
• TABLE 266 HORIBA, LTD.: PRODUCTS/SERVICES OFFERED
• TABLE 267 HORIBA, LTD.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 268 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
• TABLE 269 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 270 NIHON KOHEN CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 271 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2020-JUNE 2024
• TABLE 272 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY OVERVIEW
• TABLE 273 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCTS/SERVICES OFFERED
• TABLE 274 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCT/SERVICE ENHANCEMENTS, JANUARY 2020-JUNE 2024
• TABLE 275 EKF DIAGNOSTICS HOLDINGS PLC: DEALS, JANUARY 2020-JUNE 2024
• TABLE 276 BOULE DIAGNOSTICS AB: COMPANY OVERVIEW
• TABLE 277 BOULE DIAGNOSTICS AB: PRODUCTS/SERVICES OFFERED
• TABLE 278 BOULE DIAGNOSTICS AB: PRODUCT/SERVICE LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 279 BOULE DIAGNOSTICS AB: DEALS, JANUARY 2020-JUNE 2024
• TABLE 280 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
• TABLE 281 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
• TABLE 282 F. HOFFMANN LA-ROCHE LTD.: DEALS, JANUARY 2020-JUNE 2024

List of Figures

• FIGURE 1 MARKET SEGMENTATION
• FIGURE 2 RESEARCH DESIGN
• FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2023)
• FIGURE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: MARKET SIZE ESTIMATION METHODOLOGY:
• FIGURE 7 DATA TRIANGULATION METHODOLOGY
• FIGURE 8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
• FIGURE 9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGIONAL SNAPSHOT
• FIGURE 14 INCREASING INCIDENCE OF BLOOD DISORDERS AND RISING NUMBER OF BLOOD DONATIONS TO DRIVE MARKET
• FIGURE 15 HEMATOLOGY PRODUCTS & SERVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 17 NORTH AMERICA TO DOMINATE HEMATOLOGY ANALYZERS AND REAGENTS MARKET DURING FORECAST PERIOD
• FIGURE 18 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 19 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: VALUE CHAIN ANALYSIS
• FIGURE 20 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 21 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: ECOSYSTEM ANALYSIS
• FIGURE 22 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: ECOSYSTEM MARKET MAP
• FIGURE 23 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 24 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PATENT ANALYSIS
• FIGURE 25 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY PRODUCT, 2023 (USD)
• FIGURE 26 AVERAGE SELLING PRICE TREND OF HEMATOLOGY REAGENTS, BY PRODUCT, 2023 (USD)
• FIGURE 27 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY REGION, 2023 (USD)
• FIGURE 28 AVERAGE SELLING PRICE TREND OF HEMATOLOGY REAGENTS, BY REGION, 2023 (USD)
• FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMATOLOGY PRODUCTS
• FIGURE 30 KEY BUYING CRITERIA FOR HEMATOLOGY ANALYZERS AND PRODUCTS
• FIGURE 31 TRENDS/DISRUPTIONS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
• FIGURE 32 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: NUMBER OF DEALS & FUNDING ACTIVITIES, BY KEY PLAYER, 2018-2022 (USD MILLION)
• FIGURE 33 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022 (USD MILLION)
• FIGURE 34 VALUE OF INVESTOR DEALS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)
• FIGURE 35 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT
• FIGURE 36 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT
• FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET (2019-2023)
• FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET (2023)
• FIGURE 39 HEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 40 HEMOSTASIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 41 IMMUNOHEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 42 RANKING OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET, 2023
• FIGURE 43 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 44 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY FOOTPRINT
• FIGURE 45 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 46 EV/EBITDA OF KEY VENDORS
• FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 48 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 49 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2023)
• FIGURE 52 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023)
• FIGURE 53 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
• FIGURE 54 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 55 HORIBA, LTD.: COMPANY SNAPSHOT (2023)
• FIGURE 56 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 57 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2023)
• FIGURE 58 BOULE DIAGNOSTICS AB: COMPANY SNAPSHOT (2023)
• FIGURE 59 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)